B. Braun Medical Inc.

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Jul 26, 2023FDAMerrem — MEROPENEM

Sep 27, 2022FDAIheezo — IHEEZO

Apr 5, 2022TrialPharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults

Oct 30, 2020FDAOsmitrol — BRONCHITOL

Nov 20, 2017TrialSafety of 1 g and 2 g of Cefazolin in Pediatric Subjects

Sep 26, 2017FDAIheezo — CLOROTEKAL

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

4 patent groups across drugs · Source: FDA Orange Book

DrugExpires

IheezoSep 5, 2026 IheezoDec 11, 2033 IheezoSep 15, 2038 IheezoMay 14, 2039

Regulatory

Regulatory Timeline

19862 events

FDAOct 17

Aminess 5.2% Essential Amino Acids W/ Histadine — AMINOSYN-PF 10%

Application NDA019492 (NDA)

FDAOct 10

Aminess 5.2% Essential Amino Acids W/ Histadine — AMINOSYN II 3.5% IN PLASTIC CONTAINER

Application NDA019491 (NDA)

19871 event

FDAJan 8

Osmitrol — MANNITOL 10% IN PLASTIC CONTAINER

Application NDA019603 (NDA)

19881 event

FDAOct 17

Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container — POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Application NDA019686 (NDA)

19891 event

FDASep 29

Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container — POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Application NDA019708 (NDA)

19912 events

FDADec 19

Aminess 5.2% Essential Amino Acids W/ Histadine — AMINOSYN II 15% IN PLASTIC CONTAINER

Application NDA020041 (NDA)

FDADec 19

Aminess 5.2% Essential Amino Acids W/ Histadine — AMINOSYN II 10% IN PLASTIC CONTAINER

Application NDA020015 (NDA)

19933 events

FDAJul 30

Cefotan — CEFOTAN IN PLASTIC CONTAINER

Application NDA050694 (NDA)

FDAJul 26

Osmitrol — MANNITOL 10% IN PLASTIC CONTAINER

Application NDA020006 (NDA)

FDAFeb 5

Aminess 5.2% Essential Amino Acids W/ Histadine — NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER

Application NDA020107 (NDA)

19961 event

FDAJun 21

Merrem — MERREM IV

Application NDA050706 (NDA)

19981 event

FDAAug 26

Aminess 5.2% Essential Amino Acids W/ Histadine — PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER

Application NDA020849 (NDA)

20021 event

FDANov 26

Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container — POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%

Application NDA017648 (NDA)

20071 event

FDAAug 9

Cefotan — CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

Application NDA065430 (NDA)

20101 event

FDAOct 5

Osmitrol — ARIDOL KIT

Application NDA022368 (NDA)

20151 event

FDAApr 30

Merrem — MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

Application NDA202106 (NDA)

20171 event

FDASep 26

Iheezo — CLOROTEKAL

Application NDA208791 (NDA)

20201 event

FDAOct 30

Osmitrol — BRONCHITOL

Application NDA202049 (NDA)

20221 event

FDASep 27

Iheezo — IHEEZO

Application NDA216227 (NDA)

20231 event

FDAJul 26

Merrem — MEROPENEM

Application NDA215212 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)